Carregant...
RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise
Nucleic acid-based therapeutics like synthetic small interfering RNAs have been exploited to modulate gene function, taking advantage of RNA interference (RNAi), an evolutionally conserved biological process. Recently, the world's first RNAi drug was approved for a rare genetic disorder in the...
Guardat en:
| Publicat a: | Nucleic Acid Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mary Ann Liebert, Inc., publishers
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461149/ https://ncbi.nlm.nih.gov/pubmed/30562145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0762 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|